Kansas b2025_26 Biennium Status: Introduced

HB2218 — Amending the definition of "psilocybin" in the uniform controlled substances act to exclude the pharmaceutical composition of crystalline polymorph psilocybin and adding crystalline polymorph psilocybin to schedule IV of the uniformed controlled substance act.

Last action — Stricken from Calendar by Rule 1507

Track this bill free

No card. One bill, free forever — alerts when it moves.

  1. 1
    Introduced
  2. 2
    In Committee
  3. 3
    Passed House
  4. 4
    Passed Senate
  5. 5
    To Executive
  6. 6
    Enacted

This bill has been introduced in the House. Introduced February 03, 2025. It must pass committee before a floor vote.

Next likely step: a committee referral and hearing.

Prognosis

Not enough signal yet

Where this bill stands today.

Odds of enactment

Low

How often bills like it became law.

Not enough signal yet to read this bill's trajectory — we surface a likelihood only once there's real movement (stage, sponsorship, committee, or votes) to point to.

Prognosis reads this bill's own signals — stage, sponsorship breadth, committee status, recorded votes and cross-state momentum. Odds come from a model trained on which bills have become law.

Summary

AN ACT concerning the uniform controlled substances act; defining psilocybin to exclude the pharmaceutical composition of crystalline polymorph psilocybin; adding crystalline polymorph psilocybin to schedule IV; amending K.S.A. 2025 Supp. 65-4101 and 65-4111 and repealing the existing sections.

Bill Text

We don't have the full text on file for this bill yet.

Read HB2218 on the official Kansas source →

Action History

  1. Stricken from Calendar by Rule 1507

  2. Committee of the Whole - Passed over and retain a place on the calendar

  3. Committee of the Whole - Now working on

  4. Committee Report recommending bill be passed as amended by

  5. Hearing: Tuesday, February 11, 2025, 1:30 PM — Room 112-N

  6. Referred to House Committee on Health and Human Services

  7. Introduced

Sponsors

  • House Committee on Health and Human Services · Primary

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 0 co-sponsors · 164 not signed on

Sponsors (1)

  • House Committee on Health and Human Services

Co-sponsors (0)

None.

Not signed on (164)

164 members have not signed on to this bill.

Show all 164 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

public-safety health-insurance
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does HB2218 do?
AN ACT concerning the uniform controlled substances act; defining psilocybin to exclude the pharmaceutical composition of crystalline polymorph psilocybin; adding crystalline polymorph psilocybin to schedule IV; amending K.S.A. 2025 Supp. 65-4101 and 65-4111 and repealing the existing sections.
Who sponsors HB2218?
HB2218 is sponsored by House Committee on Health and Human Services.
What is the current status of HB2218?
This bill has been introduced in the House. Introduced February 03, 2025. It must pass committee before a floor vote.
Where can I track HB2218?
Track HB2218 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on HB2218

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of HB2218

Last checked for changes 4 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →